CuraScientific Corp
CSTF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -47.8% | – | – | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$1 | $0 | -$0 | -$0 |
| % Margin | -245.6% | 50.2% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $44 | $0 | $0 |
| Operating Expenses | $0 | $1 | $0 | $1 |
| Operating Income | -$1 | -$2 | -$0 | -$1 |
| % Margin | -384.5% | -531.7% | – | – |
| Other Income/Exp. Net | -$5 | $44 | $0 | -$1 |
| Pre-Tax Income | -$6 | $41 | -$0 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | $41 | -$0 | -$2 |
| % Margin | -2,482.5% | 9,351.4% | – | – |
| EPS | -0.008 | 0.39 | -0.032 | -0.25 |
| % Growth | -101.9% | 1,330.3% | 87.3% | – |
| EPS Diluted | -0.008 | 0.29 | -0.032 | -0.25 |
| Weighted Avg Shares Out | 757 | 106 | 7 | 7 |
| Weighted Avg Shares Out Dil | 757 | 142 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$5 | $42 | -$0 | -$1 |
| % Margin | -2,117.8% | 9,422.5% | – | – |